Alkem Laboratories Limited
ALKEM
Rang in aandelen
#2839
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Aandeelprijs
$55.51
Marktkapitalisatie
$6.64B
Verandering (1 dag)
0.52%
Verandering (1 jaar)
-11.92%
Land
IN
Handel Alkem Laboratories Limited (ALKEM)
Categorie
Healthcare
EPS voor Alkem Laboratories Limited (ALKEM)
EPS per June 2026 TTM: $1.99
Volgens de laatste financiële rapporten en de aandelenkoers van Alkem Laboratories Limited is de huidige EPS van het bedrijf (TTM) $1.99. Eind 2024 had het bedrijf een EPS van $1.80, een stijging ten opzichte van de EPS van 2023 die $1.00 bedroeg.
EPS-geschiedenis van Alkem Laboratories Limited van 2010 tot 2026
EPS aan het einde van elk jaar
| Jaar | EPS | Wijzigen |
|---|---|---|
| 2026 (TTM) | $1.99 | -6.17% |
| 2025 | $2.12 | 17.57% |
| 2024 | $1.80 | 79.83% |
| 2023 | $1.00 | -44.76% |
| 2022 | $1.81 | 0.12% |
| 2021 | $1.81 | 44.74% |
| 2020 | $1.25 | 36.59% |
| 2019 | $0.92 | 13.02% |
| 2018 | $0.81 | -29.55% |
| 2017 | $1.15 | 22.89% |
| 2016 | $0.94 | 78.39% |
| 2015 | $0.52 | -14.30% |
| 2014 | $0.61 | -19.80% |
| 2013 | $0.76 | 8.82% |
| 2012 | $0.70 | 15.60% |
| 2011 | $0.61 | 38.68% |
| 2010 | $0.44 | 0.00% |
EPS van vergelijkbare bedrijven of concurrenten
| Bedrijf | EPS | EPS-verschil | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -72.03% |
IN
|
